Mesoblast Ltd operates within the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Mesoblast Ltd with three other
companies in this sector in AUSTRALIA :
Clinuvel Pharmaceuticals Limited
sales of 31.61 million Australian Dollars [US$22.64 million]
of which 100%
(30.58 million Australian Dollars [US$21.90 million]
of which 98%
was Clinical Trials), and
Benitec Biopharma Inc
(16.60 million Australian Dollars [US$11.89 million]
During the year ended June of 2019, sales at
Mesoblast Ltd were A$23.40 million (US$16.76 million).
increase of 4.4%
versus 2018, when the company's sales were A$22.42 million.
The sales level in 2019 was fairly close to the level five years ago: in 2014, Mesoblast Ltd had sales
of A$25.98 million.